Chronic Stress Promotes Gastric Cancer Progression Via the Adrenoceptor Beta 2/PlexinA1 Pathway

Overview

Journal Cell Stress Chaperones

Publisher Elsevier

Specialty Cell Biology

Date 2024 Feb 8

PMID 38331165

Authors

Yanjie Lu

Die Cheng

Jiayu Pang

Yuqiao Peng

Shunkang Jin

Xinyu Zhang

Yuhong Li

Yanzhen Zuo

Affiliations

Soon will be listed here.

Abstract

Chronic stress is a common emotional disorder in cancer patients. Chronic stress promotes progression of gastric cancer (GC) and leads to poor outcomes. However, the underlying mechanisms remain not clear. Herein, we explored the possible mechanisms of chronic stress in GC progression. The Cancer Genome Atlas (TCGA) datasets were analyzed for differentially expressed genes. Clinical data of GC were evaluated for their association with PlexinA1 using TCGA and Kaplan-Meier-plotter databases. Chronic stress of GC patients was evaluated using the Self-Rating Anxiety Scale and Self-Rating Depression Scale. Chronic unpredictable mild stress (CUMS) was used to induce chronic stress in mice. Gastric xenograft tumor was constructed using the sewing method. Chronic stress-like behaviors were assessed using light/dark box and tail suspension tests. Protein expression was detected using immunohistochemistry and Western blot analysis. Analyses of TCGA and the Kaplan-Meier-plotter databases showed that patients with high levels of PlexinA1 in GC had worse overall survival than those with low levels of PlexinA1. A total of 36 GC patients were enrolled in the study, and about 33% of the patients had chronic stress. Compared with patients without chronic stress, higher expression levels of adrenoceptor beta 2 and PlexinA1 were observed in patients with chronic stress. The tumor size in mice under CUMS was significantly increased compared with the control mice. Adrenoceptor beta 2, PlexinA1, N-cadherin, and alpha-smooth muscle actin, as well as Ki67 were highly expressed in the tumors of CUMS group. However, E-cadherin was lowly expressed in the tumors of CUMS group. Importantly, chemical sympathectomy with 6-hydroxydopamine or treatment with a selective β2 adrenergic receptor antagonist (ICI118,551) could reverse these effects. Our findings suggest that chronic stress plays an important role in GC progression and there is a potential for blocking the epinephrine-β2AR/PlexinA1 pathway in the treatment of GC.

References

Lu Y, Xu Q, Chen L, Zuo Y, Liu S, Hu Y . Expression of semaphorin 6D and its receptor plexin-A1 in gastric cancer and their association with tumor angiogenesis. Oncol Lett. 2016; 12(5):3967-3974. PMC: 5104217. DOI: 10.3892/ol.2016.5208. View

Cormanique T, Almeida L, Rech C, Rech D, do Amaral Herrera A, Panis C . Chronic psychological stress and its impact on the development of aggressive breast cancer. Einstein (Sao Paulo). 2015; 13(3):352-6. PMC: 4943778. DOI: 10.1590/S1679-45082015AO3344. View

Markov D, Novosadova E . Chronic Unpredictable Mild Stress Model of Depression: Possible Sources of Poor Reproducibility and Latent Variables. Biology (Basel). 2022; 11(11). PMC: 9687170. DOI: 10.3390/biology11111621. View

ZUNG W . A rating instrument for anxiety disorders. Psychosomatics. 1971; 12(6):371-9. DOI: 10.1016/S0033-3182(71)71479-0. View

Guan Y, Yao W, Yu H, Feng Y, Zhao Y, Zhan X . Chronic stress promotes colorectal cancer progression by enhancing glycolysis through β2-AR/CREB1 signal pathway. Int J Biol Sci. 2023; 19(7):2006-2019. PMC: 10158030. DOI: 10.7150/ijbs.79583. View

Lu Y, Zhao H, Liu Y, Zuo Y, Xu Q, Liu L . Chronic Stress Activates PlexinA1/VEGFR2-JAK2-STAT3 in Vascular Endothelial Cells to Promote Angiogenesis. Front Oncol. 2021; 11:709057. PMC: 8415364. DOI: 10.3389/fonc.2021.709057. View

Zhou Z, Shu Y, Bao H, Han S, Liu Z, Zhao N . Stress-induced epinephrine promotes epithelial-to-mesenchymal transition and stemness of CRC through the CEBPB/TRIM2/P53 axis. J Transl Med. 2022; 20(1):262. PMC: 9172202. DOI: 10.1186/s12967-022-03467-8. View

Willner P . Reliability of the chronic mild stress model of depression: A user survey. Neurobiol Stress. 2017; 6:68-77. PMC: 5314419. DOI: 10.1016/j.ynstr.2016.08.001. View

Qiao H, Li M, Xu C, Chen H, An S, Ma X . Dendritic Spines in Depression: What We Learned from Animal Models. Neural Plast. 2016; 2016:8056370. PMC: 4736982. DOI: 10.1155/2016/8056370. View

10.

Song Y, Xu C, Liu J, Li Y, Wang H, Shan D . Heterodimerization With 5-HTR Is Indispensable for βAR-Mediated Cardioprotection. Circ Res. 2020; 128(2):262-277. DOI: 10.1161/CIRCRESAHA.120.317011. View

11.

ZUNG W . A SELF-RATING DEPRESSION SCALE. Arch Gen Psychiatry. 1965; 12:63-70. DOI: 10.1001/archpsyc.1965.01720310065008. View

12.

Antoni M, Lutgendorf S, Cole S, Dhabhar F, Sephton S, Green McDonald P . The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer. 2006; 6(3):240-8. PMC: 3146042. DOI: 10.1038/nrc1820. View

13.

Zhang X, Zhang Y, He Z, Yin K, Li B, Zhang L . Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2. Cell Death Dis. 2019; 10(11):788. PMC: 6797812. DOI: 10.1038/s41419-019-2030-2. View

14.

OShea S, Hickman R, Cortes E, Vonsattel J, Fahn S, Okur V . Neuropathological Findings in a Case of Parkinsonism and Developmental Delay Associated with a Monoallelic Variant in PLXNA1. Mov Disord. 2021; 36(11):2681-2687. DOI: 10.1002/mds.28756. View

15.

Li C, Malone K, Weiss N, Boudreau D, Cushing-Haugen K, Daling J . Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer. 2003; 98(7):1504-13. DOI: 10.1002/cncr.11663. View

16.

Yasuda T, Koiwa M, Yonemura A, Miyake K, Kariya R, Kubota S . Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination. Cell Rep. 2021; 34(8):108779. DOI: 10.1016/j.celrep.2021.108779. View

17.

Tse C, Xiang R, Bracht T, Naylor S . Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res. 2002; 62(2):542-6. View

18.

Li K, Zhang A, Li X, Zhang H, Zhao L . Advances in clinical immunotherapy for gastric cancer. Biochim Biophys Acta Rev Cancer. 2021; 1876(2):188615. DOI: 10.1016/j.bbcan.2021.188615. View

19.

Ajani J, DAmico T, Bentrem D, Chao J, Cooke D, Corvera C . Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022; 20(2):167-192. DOI: 10.6004/jnccn.2022.0008. View

20.

Priestman T, Priestman S, Bradshaw C . Stress and breast cancer. Br J Cancer. 1985; 51(4):493-8. PMC: 1977144. DOI: 10.1038/bjc.1985.71. View